Back to BCRX
Candriam S.C.A. BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
3
Latest value
$21M
Q3 2026
Peak value
$25.1M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $21.8M |
| Q2 2026 | $25.1M |
| Q3 2026 | $21M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $21M | 2.51M | — | — |
| Q2 2026 | $25.1M | 2.51M | — | — |
| Q1 2026 | $21.8M | 2.29M | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M